• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. 4.0MM VERSAPOINT RESECTING LOO; COAGULATOR-CUTTER, ENDOSCOPIC, BIPOLAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. 4.0MM VERSAPOINT RESECTING LOO; COAGULATOR-CUTTER, ENDOSCOPIC, BIPOLAR Back to Search Results
Catalog Number 01942
Device Problem Break (1069)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/18/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Were there any patient consequences? was any broken piece left in the patients body? was there any change in the patient¿s post-operative care due to the prolonged procedure? a manufacturing record evaluation was performed for the finished device batch, and no non-conformances were identified.Product release date: april 2020.Product expiry date: april 2025.Attempts are being made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
 
Event Description
It was reported that a patient underwent an unknown gynecological procedure on (b)(6) 2020 and an electrode was used.The handle broke during the procedure.The team had to wait 55 minutes until another electrode arrived.The procedure was completed using a new like device and there were no adverse patient consequences reported.Additional information was requested.
 
Manufacturer Narrative
Product complaint (b)(4).Date sent to the fda: 4/1/2021.Additional information: d9, h3.The product upon which this medwatch is based has been received, however, the product evaluation is not yet complete.Any further information derived from the evaluation will be submitted in a supplemental 3500a form.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc., or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Product complaint (b)(4).Date sent to the fda: 4/1/2021.Corrected information: d3, g1.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc., or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
(b)(4).Date sent to fda: 05/12/2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc., or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.H3 analysis summary: the device has not been returned in its original packaging.The active ring of the device is confirmed to be missing from the distal end of the electrode.The missing section of the active ring has been returned with the electrode.The remainder of the electrode show no signs of damage.No connector cable has been returned with the electrode.No electrical or functional testing will be conducted due to the condition of the device.Closer visual examination will only be conducted.All fracture faces show evidence of a brittle failure, also there are no signs of an obvious reduction on cross sectional area, indicating a non-mechanical failure mode.It is also worth noting that the fracture surfaces may have been compromised somewhat as activation may have occurred after the actual failure causing the fracture surface to be altered somewhat.Potentially, indicating failure due to surface (hydrogen) embrittlement.The device history record for batch referenced above was reviewed for non-conformances related to the nature of the complaint during the manufacturing process.The results of this review indicate there were zero non-conformances regarding the nature of the complaint associated with this lot.Product release date: april 2020.Product expiry date: april 2025.(b)(4).Date sent to fda: 05/12/2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc., or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
4.0MM VERSAPOINT RESECTING LOO
Type of Device
COAGULATOR-CUTTER, ENDOSCOPIC, BIPOLAR
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08876
MDR Report Key10976315
MDR Text Key220454098
Report Number2210968-2020-09764
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
PMA/PMN Number
K111751
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 11/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number01942
Device Lot NumberUGY2004012
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/23/2021
Initial Date Manufacturer Received 11/19/2020
Initial Date FDA Received12/09/2020
Supplement Dates Manufacturer Received03/03/2021
04/19/2021
Supplement Dates FDA Received04/01/2021
05/12/2021
Patient Sequence Number1
Patient Age40 YR
-
-